HIV Related Cancers News

Colorectal Cancer Screening for Individuals with HIV (08/24/2006)
According to an article recently published in the Archives of Internal Medicine, patients with the human immunodeficiency virus (HIV) over the age of 50 years may have a higher rate of colon cancer than healthy individuals and should be screened for this disease.

Addition of Rituxan® to CHOP Safe and Effective for AIDS-related NHL (08/16/2006)
According to an early online publication in the Journal of Clinical Oncology, the addition of Rituxan® (rituximab) to the chemotherapy combination known as CHOP is safe and effective for the treatment of AIDS-related non-Hodgkin's lymphoma.

Metastat® Shows Promise Against AIDS-related Kaposi’s Sarcoma (03/24/2006)
According to the results of a phase II clinical trial published in the Journal of Clinical Oncology, treatment with Metastat® (COL-3) reduced or eliminated detectable Kaposi’s sarcoma in some patients with acquired immune deficiency syndrome (AIDS).

CHOP Plus HAART Safe and Effective for AIDS-Related Lymphomas (03/13/2006)
According to an early online article published in the journal Cancer, the chemotherapy regimen known as CHOP in addition to highly active antiretroviral therapy (HAART) is safe and effective treatment for patients with AIDS-related lymphomas.

Lung Cancer Also Threatens HIV-Infected Population (01/26/2006)
Lung cancer is the leading cause of cancer death in the U.S. and Europe. Individuals infected with the human immunodeficiency virus (HIV) appear to have a higher risk of lung cancer than the general population, due at least in part to a higher prevalence of smoking. A review of lung cancer and HIV was published in the journal Lung Cancer.

More...

General

Colorectal Cancer Screening for Individuals with HIV (08/24/2006)
According to an article recently published in the Archives of Internal Medicine, patients with the human immunodeficiency virus (HIV) over the age of 50 years may have a higher rate of colon cancer than healthy individuals and should be screened for this disease.

Addition of Rituxan® to CHOP Safe and Effective for AIDS-related NHL (08/16/2006)
According to an early online publication in the Journal of Clinical Oncology, the addition of Rituxan® (rituximab) to the chemotherapy combination known as CHOP is safe and effective for the treatment of AIDS-related non-Hodgkin's lymphoma.

Metastat® Shows Promise Against AIDS-related Kaposi’s Sarcoma (03/24/2006)
According to the results of a phase II clinical trial published in the Journal of Clinical Oncology, treatment with Metastat® (COL-3) reduced or eliminated detectable Kaposi’s sarcoma in some patients with acquired immune deficiency syndrome (AIDS).

CHOP Plus HAART Safe and Effective for AIDS-Related Lymphomas (03/13/2006)
According to an early online article published in the journal Cancer, the chemotherapy regimen known as CHOP in addition to highly active antiretroviral therapy (HAART) is safe and effective treatment for patients with AIDS-related lymphomas.

Lung Cancer Also Threatens HIV-Infected Population (01/26/2006)
Lung cancer is the leading cause of cancer death in the U.S. and Europe. Individuals infected with the human immunodeficiency virus (HIV) appear to have a higher risk of lung cancer than the general population, due at least in part to a higher prevalence of smoking. A review of lung cancer and HIV was published in the journal Lung Cancer.

More...